Measuring the Effects of Touch Relaxation Painful Patients in Oncologie Nursing

Cancer Clinical Trial

— ToucherDétente  

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT02857114
• Other study ID #: 2014-20
• Status: Recruiting
• Phase: N/A
• First received: July 29, 2016
• Last updated: August 2, 2016
• Start date: February 2015
• Est. completion date: December 2018

Study information

• Verified date: July 2016
• Source: Assistance Publique Hopitaux De Marseille
• Contact: Michelle GAIDE
• Phone: 04 91 38 27 47
• Email: drci[@]ap-hm.fr
• Is FDA regulated: No
• Health authority: France: Agence Nationale de Sécurité du Médicament et des produits de santé
• Study type: Interventional

Clinical Trial Summary

Measure the impact of touch relaxation on pain communicative patients suffering from chronic pain of cancer origin inpatient Oncology. measure over three days the effects on pain anxiety welfare and consumption of analgesics

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 104
• Est. completion date: December 2018
• Est. primary completion date: February 2018
• Accepts healthy volunteers: No
• Gender: Both
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

hospitalized in the oncology department at least 3 days

• presenting the cancerous type of pain caused by their disease or treatment

• numerical scale pain score = 4/10

• receiving weak and strong opioids

• platelet count> 100

• can receive anxiolytic

• adult

• Patient of both sexes

• no other relaxation approaches

Exclusion Criteria:

• against indication to touch: wound, bruises, circulatory disorders, diseases psychiatiques

• risk of hematoma

• numerical scale pain score < 4/10

• understanding of the difficulties of the French language

• no receiving weak and strong opioids

Study Design

Intervention Model: Single Group Assignment, Masking: Open Label

Related Conditions & MeSH terms

• Cancer

Intervention

Other:
• massage

Locations

Country	Name	City	State
France	Hôpital de la Timone Assistance Publique Hôpitaux de Marseille	Marseille

Sponsors (1)

Lead Sponsor	Collaborator
Assistance Publique Hopitaux De Marseille

Country where clinical trial is conducted

France, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Pain	pain measurement by the scale numerical pain	3 days	No
Secondary	anxiety	measurement with the scale of COVI	3 days	No
Secondary	consumption of analgesics	daily creel analgesics and anxiolytics	3 days	No
Secondary	wellness	measure with the scale of edmonton	3 days	No